The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. Glob. Scie. Revi. [Internet]. 2026 Feb. 25 [cited 2026 May 6];48:42-5. Available from: https://scienticreview.com/index.php/gsr/article/view/602